Nifty
Sensex
:
:
9580.30
32424.10
90.20 (0.95%)
223.51 (0.69%)

Pharmaceuticals & Drugs

Rating :
N/A  (View)

BSE: 506128 | NSE: Not Listed

16.90
-0.85 (-4.79%)
29-May-2020 | 4:01PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  18.60
  •  18.60
  •  16.90
  •  17.75
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  1702
  •  0.29
  •  31.00
  •  11.65

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 14.97
  • N/A
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 56.31
  • N/A
  • 0.42

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 62.59%
  • 1.73%
  • 33.26%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 2.42%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 1.15
  • 4.69

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -3.19
  • -3.79

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 45.15
  • -4.93
  • -3.57

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 9.70
  • 11.06
  • 14.14

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.40
  • 1.08
  • 1.02

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 11.79
  • 6.25
  • 6.38

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Jun 19
Jun 18
Var%
Mar 19
Mar 18
Var%
Net Sales
25
23
9%
26
42
-39%
21
23
-10%
20
22
-7%
Expenses
24
21
13%
23
37
-38%
19
21
-10%
19
21
-9%
EBITDA
1
2
-35%
3
5
-47%
2
2
-16%
1
0
118%
EBIDTM
5%
8%
11%
12%
10%
11%
4%
2%
Other Income
0
1
-77%
0
1
-89%
0
0
33%
1
1
-31%
Interest
1
1
5%
1
1
59%
1
1
11%
1
1
2%
Depreciation
1
1
14%
1
1
11%
1
1
22%
1
1
7%
PBT
-1
0
-
0
4
-91%
0
1
-90%
-1
-1
-
Tax
0
0
-100%
0
0
0
0
0
0
0
0
0
PAT
-1
0
-
0
4
-91%
0
1
-90%
-1
-1
-
PATM
-3%
2%
1%
10%
0%
3%
-3%
-3%
EPS
-0.97
0.46
-
0.42
4.90
-91%
0.09
0.85
-89%
-0.82
-0.82
-

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Net Sales
92
109
106
95
71
103
69
56
93
Net Sales Growth
-17%
3%
11%
33%
-31%
50%
23%
-40%
 
Cost Of Goods Sold
44
53
55
50
38
67
40
32
76
Gross Profit
48
56
51
45
33
36
28
24
17
GP Margin
52%
52%
48%
47%
47%
35%
41%
42%
18%
Total Expenditure
85
99
96
82
61
91
60
48
93
Power & Fuel Cost
-
3
3
3
2
2
2
2
2
% Of Sales
-
3%
3%
3%
3%
2%
3%
3%
2%
Employee Cost
-
13
12
9
7
8
7
6
6
% Of Sales
-
12%
11%
10%
10%
8%
10%
10%
6%
Manufacturing Exp.
-
16
14
14
9
9
7
6
5
% Of Sales
-
14%
13%
15%
13%
8%
10%
10%
5%
General & Admin Exp.
-
6
6
4
3
3
2
2
2
% Of Sales
-
6%
6%
5%
5%
3%
3%
3%
2%
Selling & Distn. Exp.
-
7
4
1
1
1
2
1
1
% Of Sales
-
6%
4%
1%
1%
1%
2%
2%
1%
Miscellaneous Exp.
-
1
2
0
1
1
0
0
1
% Of Sales
-
1%
2%
0%
1%
1%
0%
0%
1%
EBITDA
7
10
10
12
10
12
8
7
0
EBITDA Margin
7%
9%
9%
13%
14%
12%
12%
13%
0%
Other Income
1
2
1
1
1
1
1
1
1
Interest
5
4
4
5
4
4
4
4
4
Depreciation
4
4
4
4
3
3
2
2
2
PBT
-1
5
3
5
3
5
4
3
-5
Tax
0
1
2
1
1
1
1
1
-2
Tax Rate
0%
28%
65%
22%
28%
22%
27%
35%
46%
PAT
-1
3
1
4
2
4
2
2
-3
PAT before Minority Interest
-1
3
1
4
3
4
2
2
-3
Minority Interest
0
0
0
0
0
0
0
0
0
PAT Margin
-1%
3%
1%
4%
4%
4%
4%
3%
-3%
PAT Growth
-124%
211%
-71%
47%
-41%
71%
45%
161%
 
EPS
-1.28
3.88
1.25
4.33
2.94
5.00
2.92
2.01
-3.29

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Shareholder's Funds
36
33
31
28
25
21
18
18
Share Capital
8
8
8
8
8
8
8
8
Total Reserves
27
24
23
19
17
12
10
10
Non-Current Liabilities
23
18
18
23
27
22
17
12
Secured Loans
16
12
13
14
16
17
12
8
Unsecured Loans
5
5
5
9
9
4
4
4
Long Term Provisions
0
0
0
0
0
0
0
0
Current Liabilities
36
37
36
29
31
41
25
30
Trade Payables
7
8
8
3
9
22
9
13
Other Current Liabilities
13
14
13
11
8
7
8
3
Short Term Borrowings
16
15
16
13
12
10
7
13
Short Term Provisions
0
0
0
2
2
1
1
0
Total Liabilities
95
87
86
79
83
83
60
59
Net Block
51
44
47
38
36
36
33
33
Gross Block
62
50
51
59
55
51
46
45
Accumulated Depreciation
11
7
4
21
18
15
13
11
Non Current Assets
58
51
55
49
45
37
35
38
Capital Work in Progress
0
0
0
2
1
1
0
0
Non Current Investment
0
0
0
1
1
1
1
1
Long Term Loans & Adv.
6
7
7
8
7
0
2
4
Other Non Current Assets
0
0
0
0
0
0
0
0
Current Assets
37
36
31
31
38
46
25
22
Current Investments
0
0
0
0
0
0
0
0
Inventories
8
8
8
7
7
16
6
7
Sundry Debtors
19
19
19
19
24
25
14
11
Cash & Bank
1
2
1
0
2
1
1
-1
Other Current Assets
9
4
0
0
5
4
4
4
Short Term Loans & Adv.
5
5
3
4
5
4
4
4
Net Current Assets
1
-1
-6
2
7
5
0
-8
Total Assets
95
87
86
79
83
83
60
59

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Cash From Operating Activity
9
13
16
3
0
0
6
1
PBT
5
3
5
3
5
3
3
-5
Adjustment
8
10
9
3
3
2
2
2
Changes in Working Capital
-2
1
4
-2
-7
-5
1
4
Cash after chg. in Working capital
10
14
17
5
2
1
6
1
Interest Paid
0
0
0
0
0
0
0
0
Tax Paid
-1
-1
-1
-1
-2
-1
0
0
Other Direct Exp. Paid
0
0
0
0
0
0
0
0
Extra & Other Items
0
0
0
0
0
0
0
0
Cash From Investing Activity
-11
-5
-10
-6
-4
-6
-1
-2
Net Fixed Assets
0
6
9
0
0
0
0
Net Investments
0
0
1
0
0
0
0
Others
-11
-11
-20
-6
-4
-6
-1
Cash from Financing Activity
1
-7
-5
1
6
6
-3
-1
Net Cash Inflow / Outflow
-1
1
0
-2
1
0
1
-1
Opening Cash & Equivalents
1
0
0
2
1
1
-1
0
Closing Cash & Equivalent
0
1
0
0
2
1
1
-1

Financial Ratios

Standalone /

Consolidated
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Book Value (Rs.)
42
38
37
32
30
25
22
21
ROA
4%
1%
4%
3%
5%
3%
3%
-5%
ROE
10%
3%
13%
10%
18%
13%
9%
-16%
ROCE
12%
10%
14%
11%
16%
14%
14%
-2%
Fixed Asset Turnover
1.94
2.08
1.72
1.26
1.95
1.44
1.27
2.12
Receivable days
64
65
73
110
86
101
79
44
Inventory Days
27
27
28
35
40
58
42
26
Payable days
28
31
24
38
65
94
83
52
Cash Conversion Cycle
62
61
77
107
61
64
37
18
Total Debt/Equity
1.17
1.13
1.26
1.51
1.63
1.60
1.47
1.59
Interest Cover
2
2
2
2
2
2
2
0

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.